Literature DB >> 36050587

Problem-solving therapy can reduce psychological distress in patients with Cushing's disease: a randomized controlled trial.

Cem Sulu1, Gamze Karadayi Kaynak2, Tolga Koskun2, Oguzhan Koca3, Tevhide Betul Icli3, Yasin Kavla4, Hande Mefkure Ozkaya1,5, Senol Turan4, Mehmet Eskin6, Pinar Kadioglu7,8,9.   

Abstract

OBJECTIVE: To evaluate the effects of online group problem-solving therapy (PST) for reducing negative problem orientation (NPO), psychological distress, and increasing quality of life in patients with Cushing's disease (CD).
METHODS: In this randomized trial, we allocated 55 eligible patients to either PST (n = 28) or treatment as usual (TAU) (n = 27) groups. The analyses primarily relied on intent-to-treat (ITT) principle and were repeated with intervention completers (per-protocol analyses). Social problem-solving inventory-revised short form, Beck Depression Inventory (BDI), General Health Questionnaire-12 (GHQ-12), Perceived Stress Scale (PSS), The Satisfaction with Life Scale, and Cushing's Quality of Life scale were used. Pre-test, post-test, and follow-up measures were obtained. Linear mixed models were used to compare PST and treatment as usual (TAU) groups across time.
RESULTS: Of the total 55 patients with CD, the mean age was 46 ± 12 years, 49 patients (89%) were female, and 41 patients (74.5%) were in remission. The patients within the PST and TAU groups were similar in terms of age, sex, and disease activity. ITT analyses showed a greater reduction of NPO scores in patients who received PST as compared to patients who received usual care (df = 45.9, p = 0.029, Cohen's d = 0.47). The decrease in NPO was sustained at follow-up (mean difference: - 2.2, p = 0.007). Results of the ITT analyses revealed no superior benefits of the intervention for psychological distress. However, per-protocol analyses demonstrated that PST provided a greater decrease in BDI, PSS, and GHQ-12 scores.
CONCLUSION: PST may decrease NPO and improve the psychological well-being of patients with CD.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Cushing’s disease; Negative problem orientation; Problem-solving therapy; Psychological distress

Year:  2022        PMID: 36050587     DOI: 10.1007/s11102-022-01275-3

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   3.599


  42 in total

1.  Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure.

Authors:  A Colao; R Pivonello; S Spiezia; A Faggiano; D Ferone; M Filippella; P Marzullo; G Cerbone; M Siciliani; G Lombardi
Journal:  J Clin Endocrinol Metab       Date:  1999-08       Impact factor: 5.958

Review 2.  Diagnosis and complications of Cushing's syndrome: a consensus statement.

Authors:  G Arnaldi; A Angeli; A B Atkinson; X Bertagna; F Cavagnini; G P Chrousos; G A Fava; J W Findling; R C Gaillard; A B Grossman; B Kola; A Lacroix; T Mancini; F Mantero; J Newell-Price; L K Nieman; N Sonino; M L Vance; A Giustina; M Boscaro
Journal:  J Clin Endocrinol Metab       Date:  2003-12       Impact factor: 5.958

3.  Subtle cognitive impairments in patients with long-term cure of Cushing's disease.

Authors:  Jitske Tiemensma; Nieke E Kokshoorn; Nienke R Biermasz; Bart-Jan S A Keijser; Moniek J E Wassenaar; Huub A M Middelkoop; Alberto M Pereira; Johannes A Romijn
Journal:  J Clin Endocrinol Metab       Date:  2010-04-06       Impact factor: 5.958

4.  Towards a better quality of life (QoL) for patients with pituitary diseases: results from a focus group study exploring QoL.

Authors:  Cornelie D Andela; Nicolasine D Niemeijer; Margreet Scharloo; Jitske Tiemensma; Shaaji Kanagasabapathy; Alberto M Pereira; Noëlle G A Kamminga; Ad A Kaptein; Nienke R Biermasz
Journal:  Pituitary       Date:  2015-02       Impact factor: 4.107

Review 5.  Cushing's syndrome.

Authors:  André Lacroix; Richard A Feelders; Constantine A Stratakis; Lynnette K Nieman
Journal:  Lancet       Date:  2015-05-21       Impact factor: 79.321

Review 6.  The Treatment of Cushing's Disease.

Authors:  Rosario Pivonello; Monica De Leo; Alessia Cozzolino; Annamaria Colao
Journal:  Endocr Rev       Date:  2015-06-11       Impact factor: 19.871

7.  Negative illness perceptions are associated with impaired quality of life in patients after long-term remission of Cushing's syndrome.

Authors:  Jitske Tiemensma; Adrian A Kaptein; Alberto M Pereira; Johannes W A Smit; Johannes A Romijn; Nienke R Biermasz
Journal:  Eur J Endocrinol       Date:  2011-07-28       Impact factor: 6.664

8.  The long-term outcome of pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing's disease.

Authors:  J Estrada; M Boronat; M Mielgo; R Magallón; I Millan; S Díez; T Lucas; B Barceló
Journal:  N Engl J Med       Date:  1997-01-16       Impact factor: 91.245

9.  Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline.

Authors:  Lynnette K Nieman; Beverly M K Biller; James W Findling; M Hassan Murad; John Newell-Price; Martin O Savage; Antoine Tabarin
Journal:  J Clin Endocrinol Metab       Date:  2015-07-29       Impact factor: 5.958

10.  Persistent body fat mass and inflammatory marker increases after long-term cure of Cushing's syndrome.

Authors:  María-José Barahona; Nuria Sucunza; Eugenia Resmini; José-Manuel Fernández-Real; Wifredo Ricart; José-María Moreno-Navarrete; Teresa Puig; Jordi Farrerons; Susan M Webb
Journal:  J Clin Endocrinol Metab       Date:  2009-06-09       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.